Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-03-01 Sale | 2023-03-02 5:36 pm | Karyopharm Therapeutics Inc. | KPTI | Mitchener Stephen SVP, Chief Business Officer | 6,357 | $3.0292 | $19,257 | 128,313 (Direct) | View |
| 2021-12-02 Sale | 2021-12-03 6:17 pm | Karyopharm Therapeutics Inc. | KPTI | Mitchener Stephen SVP, Chief Business Officer | 499 | $6.69 | $3,338 | 3,296 (Direct) | View |
| 2021-06-02 Sale | 2021-06-03 4:06 pm | Karyopharm Therapeutics Inc. | KPTI | Mitchener Stephen SVP, Chief Business Officer | 528 | $9.29 | $4,905 | 2,472 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-02-28 Option Award | 2023-03-02 5:36 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Mitchener Stephen SVP, Chief Business Officer | 60,000 | $0 | 128,313 (Direct) | View |
| 2022-08-31 Option Award | 2022-09-01 9:03 pm | N/A 2032-08-30 | Karyopharm Therapeutics Inc. | KPTI | Mitchener Stephen SVP, Chief Business Officer | 50,000 | $0 | 100,546 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 3:15 pm | N/A 2032-02-27 | Karyopharm Therapeutics Inc. | KPTI | Mitchener Stephen SVP, Chief Business Officer | 106,650 | $0 | 109,946 (Direct) | View |
| 2021-05-30 Exercise | 2021-06-01 4:05 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Mitchener Stephen SVP, Chief Business Officer | 1,500 | $0 | 4,500 (Direct) | View |
Ownership | 2021-01-05 7:39 pm | N/A 2030-11-29 | Karyopharm Therapeutics Inc. | KPTI | Mitchener Stephen SVP, Chief Business Officer | 0 | $0 | 103,000 (Direct) | View |